Page 9 - 2020_02-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
498 Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance Senna Staessens et al.
508 Variable readthrough responsiveness of nonsense mutations in hemophilia A Lluis Martorell et al.
Stem Cell Transplantation
519 Validation of Minnesota acute graft-versus-host disease Risk Score Margaret L. MacMillan et al.
Letters to the Editor
Letters are available online only at www.haematologica.org/content/105/2.toc
e43 CD117hi expression identifies a human fetal hematopoietic stem cell population with high proliferation and self-renewal potential Loïc Maillard, et al.
http://www.haematologica.org/content/105/2/e43
e48 Sequential cellular niches control the generation of enucleated erythrocytes from human pluripotent stem cells Jun Shen, et al.
http://www.haematologica.org/content/105/2/e48
e52 Characterization of the phenotype of human eosinophils and their progenitors in the bone marrow of healthy individuals Marwan Hassani et al.
http://www.haematologica.org/content/105/2/e52
e57 Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells Inge Baas et al.
http://www.haematologica.org/content/105/2/e57
e61 Targetable driver mutations in multicentric reticulohistiocytosis Norihiro Murakami et al.
http://www.haematologica.org/content/105/2/e61
e65 Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia
Fiorina Giona et al. http://www.haematologica.org/content/105/2/e65
e68 Rac1/2 activation promotes FGFR1 driven leukemogenesis in stem cell leukemia/lymphoma syndrome Tianxiang Hu et al.
http://www.haematologica.org/content/105/2/e68
e72 Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma Grzegorz S. Nowakowski et al.
http://www.haematologica.org/content/105/2/e72
e76 Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma Thijs W.H. Flinsenberg et al.
http://www.haematologica.org/content/105/2/e76
e80 Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma
Lisa C. Holthof et al. http://www.haematologica.org/content/105/2/e80
Case Reports
Case Reports are available online only at www.haematologica.org/content/105/2.toc
e84 Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms Gaurav Goyal et al.
http://www.haematologica.org/content/105/2/e84
Coagulation & its Disorders
Haematologica 2020; vol. 105 no. 2 - February 2020 http://www.haematologica.org/